Chronic obstructive pulmonary disease

References

• World Health Organization. WHO announces COVID-19 outbreak a pandemic. https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic. Accessed January 5, 2020.
   Google Scholar
• Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS One. 2020; 15(5):e0233147. doi:10.1371/journal.pone.0233147.
   PubMed Web of Science ®Google Scholar
• Leung JM, Niikura M, Yang CWT, Sin DD. COVID-19 and COPD. Eur Respir J. 2020;56(2):2002108. doi:10.1183/13993003.02108-2020.
   PubMed Web of Science ®Google Scholar
• Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941. doi:10.1016/j.rmed.2020.105941.
   PubMed Web of Science ®Google Scholar
• Olloquequi J. COVID-19 Susceptibility in chronic obstructive pulmonary disease. Eur J Clin Invest. 2020 ;50(10):e13382. doi:10.1111/eci.13382. Epub 2020 Sep 2. PMID: 32780415; PMCID: PMC7435530.
   PubMed Web of Science ®Google Scholar
• Hu W, Dong M, Xiong M, et al. Clinical Courses and Outcomes of Patients with Chronic Obstructive Pulmonary Disease During the COVID-19 Epidemic in Hubei, China. Int J Chron Obstruct Pulmon Dis. 2020;15:2237–2248. doi:10.2147/COPD.S265004.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Martinez FJ, Ferguson GT, et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med. 2020;383(1):35–48. doi:10.1056/NEJMoa1916046.
   PubMed Web of Science ®Google Scholar
• Lipson DA, Crim C, Criner GJ, et al. Reduction in all-cause mortality with fluticasone furoate/umeclidinium/vilanterol in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2020;201(12):1508–1516. doi:10.1164/rccm.201911-2207OC.
   PubMed Web of Science ®Google Scholar
• Lipson DA, Barnhart F, Brealey N, et al. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. N Engl J Med. 2018;378(18):1671–1680. doi:10.1056/NEJMoa1713901.
   PubMed Web of Science ®Google Scholar
• Criner GJ, Celli BR, Singh D, et al. Predicting response to benralizumab in chronic obstructive pulmonary disease: Analyses of GALATHEA and TERRANOVA studies. Lancet Respir Med. 2020; 8(2):158–170. doi:10.1016/S2213-2600(19)30338-8.
   PubMed Web of Science ®Google Scholar
• Criner GJ, Celli BR, Brightling CE, et al. GALATHEA Study Investigators; TERRANOVA Study Investigators. N Engl J Med. 2019 ;381(11):1023–1034. 12doi:10.1056/NEJMoa1905248.
   PubMed Web of Science ®Google Scholar
• Lacasse Y, Series F, Corbeil F, INOX Trial Group, et al. Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2020;383(12):1129–1138. doi:10.1056/NEJMoa2013219.
   PubMed Web of Science ®Google Scholar
• Tan D, Walline JH, Ling B, et al. High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial. Crit Care. 2020;24(1):489. doi:10.1186/s13054-020-03214-9.
   PubMed Web of Science ®Google Scholar
• Duiverman ML, Vonk JM, Bladder G, et al. Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: A randomised controlled trial. Thorax. 2020;75(3):244–252. doi:10.1136/thoraxjnl-2019-213303.
   PubMed Web of Science ®Google Scholar
• Tanabe N, Sato S, Oguma T, et al. Associations of airway tree to lung volume ratio on computed tomography with lung function and symptoms in chronic obstructive pulmonary disease. Respir Res. 2019;20:77. doi:10.1186/s12931-019-1047-5.
   Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017 ; 195(5):557–582. doi:10.1164/rccm.201701-0218PP. PMID: 28128970.
   PubMed Web of Science ®Google Scholar
• Smith BM, Kirby M, Hoffman EA, for the MESA Lung, CanCOLD, and SPIROMICS Investigators, et al. Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults. JAMA. 2020;323(22):2268–2280. doi:10.1001/jama.2020.6918.
   Web of Science ®Google Scholar
• Çolak Y, Afzal S, Nordestgaard BG, Vestbo J, Lange P. Prevalence, characteristics, and prognosis of early chronic obstructive pulmonary disease. the copenhagen general population study. Am J Respir Crit Care Med. 2020;201(6):671–680. E22. doi:10.1164/rccm.201908-1644OC.
   PubMed Web of Science ®Google Scholar
• Adibi A, Sin DD, Safari A, et al. The acute COPD exacerbation prediction tool (ACCEPT): A modelling study. The Lancet Respiratory Medicine. 2020;8(10):1013–1021. doi:10.1016/S2213-2600(19)30397-2.
   Web of Science ®Google Scholar